Abstract:Objective To detect the platelet inhibition of aspirin and clopidogrel in patients after percutaneous transluminal angioplasty and stenting(PTAS) using a thromboelastograph(TEG) instrument in order to guide the individualized adjustment of anti-platelet aggregation drugs after PTAS.Methods The clinical data of 65 patients with ischemic stroke or transient ischemic attack included from Nanjing Stroke Registry Program were analyzed retrospectively.Venous blood samples were collected at day 3 after PTAS.A TEG instrument was used to detect arachidonic acid(AA)-induced inhibition rate of platelet aggregation and adenosine diphosphate(ADP) receptor-induced inhibition rate of platelet aggregation.The AA pathway and ADP receptor-induced inhibition rate of platelet aggregation,as well as the response differences of the patients between aspirin and clopidogrel therapy were compared.Results ①The inhibition rate(80±28%) of aspirin for the AA pathway was significantly higher than that(53±31%) of clopidogrel for the ADP receptor pathway(P<0.01).②Of the 65 patients,the therapeutic effects in 45(69.2%),8(12.3%),7(10.8%) and 5(7.7%) patients were good,effective,low response,and ineffective in the aspirin group,and those in 19(29.2%),14(21.5%),23(35.4%) and 9(13.8%) were good,effective,low response,and ineffective in the clopidogrel group.Of those who had a good response to aspirin,3 had no response to clopidogrel and 14 had low response to clopidogrel;of those who had a good response to clopidogrel,all responded well or effective to aspirin.Of those who had low response to clopidogrel,4 had low response to aspirin,5 had a good response to aspirin,and 14 had good results.The two efficacies had some relevance(χ2=33.311,P<0.01).③A total of 53 patients had a good+effective response to aspirin,and 12 had low response+ineffective to aspirin,while 33 and 32 patients had good+effective and low response+ineffective to clopidogrel.There was significant difference in efficacy between the two drugs(χ2m=15.042,P<0.01).Conclusion Using TEG instrument to detect the inhibition rate of platelet aggregation in patients after PTAS is beneficial to guide the development of therapeutic scheme for individualized anti-platelet aggregation in clinical practice.The inhibitory effect of platelet aggregation of aspirin after PTAS is stronger than that of clopidogrel.The patients show differential responses to aspirin and clopidogrel therapy.Some patients who have low response to clopidogrel may respond well or may be effective to aspirin.

Experimental Monitoring of Aspirin Efficacy in elderly hypertensive patients by TEG

Aspirin Resistance in the Elder Cardio-Cerebral-Vascular Diseases Patients

Platelet aggregation function in apparently healthy elderly Chinese: results from a multi-center investigation

A Laboratory Research of Aspirin Resistance

Clinical correlation study on aspirin resistance

Comparison Between Urinary 11-Dehydrothromboxane B2 Detection and Platelet Light Transmission Aggregometry (lta) Assays for Evaluating Aspirin Response in Elderly Patients with Coronary Artery Disease

Comparison of Flow Cytometry,ELISA and Thrombelastograph Monitoring Antiplatelet Therapy in Patients with Acute Cerebral Infarction

Evaluation of the efficacy of anti-platelet aggregation drugs in patients using thromboelastograph after percutaneous transluminal angioplasty and stenting

Application Of Thromboelastography In Evaluating Effects Of Aspirin With Or Without Clopidogrel Treatment As Well As Predictive Factors For Aspirin Resistance In Patients With Coronary Artery Disease

ASSA14-03-38 Comparison of Urinary11-DehydrothromboxaneB2 detection and Plasma LTA Assay for evaluating aspirin response in the Aged Patients with Coronary Artery Disease

Monitoring of antiplatelet therapy and changes of mean platelet volume after percutaneous coronary intervention in the patients with coronary heart disease

A comparison of three platelet function tests in ischemic stroke patients with antiplatelet therapy

Aspirin Resistance: Clinical Significance and Genetic Polymorphism

Anti-aggregation Effect and Short-term Safety Evaluation of Low-dose Aspirin Therapy in the Elderly Chinese Population: a Multicenter Randomized Controlled Clinical Trial

Association Between Renal Function and Platelet Reactivity During Aspirin Therapy in Elderly Patients with Atherosclerotic Cardiovascular Disease

Residual Platelet Reactivity is Preferred over Platelet Inhibition Rate in Monitoring Antiplatelet Efficacy: Insights Using Thrombelastography

The Prevalence, Risk Factors and Prognosis of Aspirin Resistance in Elderly Male Patients with Cardiovascular Disease

Evaluating the effect of different doses of aspirin on the platelet inhibition rate by thromboelastography

Thrombelastography in monitoring aspirin effect on acute ischemic stroke

Quantifying the effect of antiplatelet therapy by whole blood platelet aggregometry

The clinical and laboratory research on aspirin resistance in cardiovascular and cerebrovascular patients